Your browser doesn't support javascript.
loading
Efficacy and safety of olaparib according to age in BRCA1/2-mutated patients with recurrent platinum-sensitive ovarian cancer: Analysis of the phase III SOLO2/ENGOT-Ov21 study.
Trillsch, Fabian; Mahner, Sven; Ataseven, Beyhan; Asher, Rebecca; Aryal, Nanda; Dubot, Coraline; Clamp, Andrew; Penson, Richard T; Oza, Amit; Amit, Amnon; Huzarski, Tomasz; Casado, Antonio; Scambia, Giovanni; Friedlander, Michael; Colombo, Nicoletta; Fujiwara, Keiichi; Sonke, Gabe S; Denys, Hannelore; Lowe, Elizabeth S; Lee, Chee K; Pujade-Lauraine, Eric.
Afiliación
  • Trillsch F; Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Munich, Germany. Electronic address: Fabian.Trillsch@med.uni-muenchen.de.
  • Mahner S; Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Munich, Germany.
  • Ataseven B; Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Munich, Germany; Ev. Kliniken Essen Mitte, Essen, Germany.
  • Asher R; University of Sydney, Camperdown, Sydney, Australia.
  • Aryal N; University of Sydney, Camperdown, Sydney, Australia.
  • Dubot C; Institut Curie, Hôpital René Huguenin, Saint Cloud and GINECO, France.
  • Clamp A; The Christie NHS Foundation Trust, Manchester, UK.
  • Penson RT; Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.
  • Oza A; Princess Margaret Cancer Centre, Toronto, Canada.
  • Amit A; Rambam Health Care Campus, affiliated with Rappaport Faculty of Medicine, Technion, Haifa, Israel.
  • Huzarski T; Pomeranian Medical University, Szczecin, Poland.
  • Casado A; Hospital Clínico San Carlos, Instituto de Investigación Sanitaria (IdISSC) and CIBERONC, Madrid, Spain.
  • Scambia G; Fondazione Policlinico Universitario A Gemelli IRCCS, Università Cattolica, Rome, Italy.
  • Friedlander M; University of New South Wales Clinical School, Prince of Wales Hospital, Randwick, Australia.
  • Colombo N; University of Milan-Bicocca and IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Fujiwara K; Saitama Medical University International Medical Center, Saitama and Gynecologic Oncology Trial and Investigation Consortium (GOTIC), Japan.
  • Sonke GS; The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Denys H; Ghent University Hospital, Ghent, Belgium.
  • Lowe ES; AstraZeneca, Gaithersburg, MD, USA.
  • Lee CK; University of Sydney, Camperdown, Sydney, Australia.
  • Pujade-Lauraine E; ARCAGY-GINECO Université Paris Descartes, AP-HP, Paris, France.
Gynecol Oncol ; 165(1): 40-48, 2022 04.
Article en En | MEDLINE | ID: mdl-35115180
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Calidad de Vida Tipo de estudio: Clinical_trials / Diagnostic_studies Aspecto: Patient_preference Límite: Aged / Child, preschool / Female / Humans Idioma: En Revista: Gynecol Oncol Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Calidad de Vida Tipo de estudio: Clinical_trials / Diagnostic_studies Aspecto: Patient_preference Límite: Aged / Child, preschool / Female / Humans Idioma: En Revista: Gynecol Oncol Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos